Annual Total Long Term Liabilities
$250.35 M
-$16.06 M-6.03%
December 31, 2023
Summary
- As of February 7, 2025, TSVT annual total long term liabilities is $250.35 million, with the most recent change of -$16.06 million (-6.03%) on December 31, 2023.
- During the last 3 years, TSVT annual total long term liabilities has risen by +$88.22 million (+54.42%).
- TSVT annual total long term liabilities is now -16.96% below its all-time high of $301.46 million, reached on December 31, 2021.
Performance
TSVT Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$231.65 M
-$4.24 M-1.80%
September 30, 2024
Summary
- As of February 7, 2025, TSVT quarterly total long term liabilities is $231.65 million, with the most recent change of -$4.24 million (-1.80%) on September 30, 2024.
- Over the past year, TSVT quarterly long term liabilities has dropped by -$34.73 million (-13.04%).
- TSVT quarterly long term liabilities is now -25.13% below its all-time high of $309.41 million, reached on June 30, 2022.
Performance
TSVT Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
TSVT Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.0% | -13.0% |
| 3 y3 years | +54.4% | -13.1% |
| 5 y5 years | - | -13.1% |
TSVT Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.0% | at low | -25.1% | at low |
| 5 y | 5-year | -17.0% | +54.4% | -25.1% | +59.4% |
| alltime | all time | -17.0% | +54.4% | -25.1% | +59.4% |
2seventy Bio Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $231.65 M(-1.8%) |
| Jun 2024 | - | $235.89 M(-3.0%) |
| Mar 2024 | - | $243.21 M(-2.9%) |
| Dec 2023 | $250.35 M(-6.0%) | $250.35 M(-6.0%) |
| Sep 2023 | - | $266.38 M(-1.8%) |
| Jun 2023 | - | $271.32 M(+2.7%) |
| Mar 2023 | - | $264.18 M(-0.8%) |
| Dec 2022 | $266.40 M | $266.40 M(-12.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $305.67 M(-1.2%) |
| Jun 2022 | - | $309.41 M(+3.8%) |
| Mar 2022 | - | $298.19 M(-1.1%) |
| Dec 2021 | $301.46 M(+85.9%) | $301.46 M(+107.5%) |
| Sep 2021 | - | $145.29 M(-4.0%) |
| Jun 2021 | - | $151.27 M(-6.7%) |
| Dec 2020 | $162.12 M(-3.4%) | $162.12 M |
| Dec 2019 | $167.86 M | - |
FAQ
- What is 2seventy bio annual total long term liabilities?
- What is the all time high annual total long term liabilities for 2seventy bio?
- What is 2seventy bio annual total long term liabilities year-on-year change?
- What is 2seventy bio quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for 2seventy bio?
- What is 2seventy bio quarterly long term liabilities year-on-year change?
What is 2seventy bio annual total long term liabilities?
The current annual total long term liabilities of TSVT is $250.35 M
What is the all time high annual total long term liabilities for 2seventy bio?
2seventy bio all-time high annual total long term liabilities is $301.46 M
What is 2seventy bio annual total long term liabilities year-on-year change?
Over the past year, TSVT annual total long term liabilities has changed by -$16.06 M (-6.03%)
What is 2seventy bio quarterly total long term liabilities?
The current quarterly long term liabilities of TSVT is $231.65 M
What is the all time high quarterly long term liabilities for 2seventy bio?
2seventy bio all-time high quarterly total long term liabilities is $309.41 M
What is 2seventy bio quarterly long term liabilities year-on-year change?
Over the past year, TSVT quarterly total long term liabilities has changed by -$34.73 M (-13.04%)